D'Tang Pharmaceutical's IPO

D'Tang Pharmaceutical raised a round of funding on August 22, 2017. Investors include Public.

D'Tang Pharmaceutical (大唐汉方) (NEEQ: 872080) is a Chinese medicine research and development company, mainly engaged in proprietary Chinese medicine preparations, raw materials research and deve…

Articles about D'Tang Pharmaceutical's IPO: